Suchergebnisse - "Elazar, Assaf"

PubPharm (24)

1

Computational design of BclxL inhibitors that target transmembrane domain interactions

enthalten in: bioRxiv.org | 2024

von Duart, G. | Elazar, A. | Weinstein, J. | +5

2

DE-NOVO DESIGNED TRANSMEMBRANE POLYPEPTIDES AND THEIR USES IN CELLULAR IMMUNOTHERAPY

enthalten in: Europäisches Patentamt | 2023

von FLEISHMAN SAREL | ELAZAR ASSAF | WEINSTEIN JONATHAN Y | +3

3

DE-NOVO DESIGNED TRANSMEMBRANE POLYPEPTIDES AND THEIR USES IN CELLULAR IMMUNOTHERAPY

enthalten in: Europäisches Patentamt | 2023

von FLEISHMAN SAREL | ELAZAR ASSAF | WEINSTEIN JONATHAN Y | +3

4

DE-NOVO DESIGNED TRANSMEMBRANE POLYPEPTIDES AND THEIR USES IN CELLULAR IMMUNOTHERAPY

enthalten in: Europäisches Patentamt | 2023

von FLEISHMAN SAREL | ELAZAR ASSAF | WEINSTEIN JONATHAN Y | +3

5

DE-NOVO DESIGNED TRANSMEMBRANE POLYPEPTIDES AND THEIR USES IN CELLULAR IMMUNOTHERAPY

enthalten in: Europäisches Patentamt | 2023

von FLEISHMAN SAREL | ELAZAR ASSAF | WEINSTEIN JONATHAN Y | +3

6

Computational design of BclxL inhibitors that target transmembrane domain interactions

enthalten in: Proceedings of the National Academy of Sciences of the United States of America | 2023

von Duart, G. | Elazar, A. | Weinstein, J. | +5

7

De-novo designed transmembrane polypeptides and their uses in cellular immunotherapy

enthalten in: Europäisches Patentamt | 2023

von FLEISHMAN SAREL | ELAZAR ASSAF | WEINSTEIN JONATHAN Y | +3

8

De-novo designed transmembrane polypeptides and their uses in cellular immunotherapy

enthalten in: Europäisches Patentamt | 2023

von FLEISHMAN SAREL | ELAZAR ASSAF | WEINSTEIN JONATHAN Y | +3

9

De novo designed transmembrane domains tune engineered receptor functions

enthalten in: bioRxiv.org | 2022

von Elazar, A. | Chandler, N. | Davey, A. | +8

10

De novo-designed transmembrane domains tune engineered receptor functions

enthalten in: eLife | 2022

von Elazar, A. | Chandler, N. | Davey, A. | +8